Publications
1. Current status of molecular biosensors. Medical Device Technology, 2003;14:10-5.
2. Nanodiagnostics: Application of Nanotechnology in Molecular Diagnostics. Expert Rev Mol Diagn 2003;3:153-161.
3. Nanotechnology-based Lab-on-a-Chip Devices. In, Encyclopedia of Diagnostic Genomics and Proteomics, Marcel Dekkar Inc, New York, 2005:891-895.
4. Nanotechnology in Clinical Laboratory Diagnostics. Clinica Chimica Acta 2005;354:37-54.
5. Nanotechnology-based Drug Delivery for Cancer. TCRT 2005;4: 311-314.
6. The role of nanobiotechnology in drug discovery. Drug Discovery Today 2005;10:1435-1442.
7. Role of Nanobiotechnology in Developing Personalized Medicine for Cancer. Technology in Cancer Research & Treatment 2005;4:645-650
8. Nanobiotechnology in Molecular Diagnostics. Horizon Scientific Press, Norwich, UK, 2006.
9. Nanoparticles as targeting ligands. Trends Biotechnol 2006;24:143-5.
10. Role of nanotechnology in developing new therapies for diseases of the nervous system (editorial). Nanomedicine 2006;1: 9-12.
11. Jain V, Jain KK. Impact of Nanotechnology on Healthcare. Nanotechnology Law & Business 2006;3:411-418.
12. Role of Nanobiotechnology-based Drug Delivery in the Development of Nanomedicine. In, Thassu D, et al (eds) Nanoparticulate Drug Delivery Systems: Recent Trends and Emerging Technologies, Informa Healthcare, 2007:173-183.
13. Nanobiotechnology-based drug delivery to the central nervous system. Neurodegenerative Dis 2007;4:287-291.
14. Nanomedicine. In, Shoseyov O & Levy I (eds) NanoBioTechnology: BioInspired device and materials of the future. Humana Press, Totowa, NJ, 2008:303-327.
15. Use of nanoparticles for drug delivery in glioblastoma multiforme. Exp Rev Neurother 2007;7:363-372.
16. Applications of Nanobiotechnology in Clinical Diagnostics. Clin Chem 2007;53:2002-2009.
17. Recent advances in nanooncology. Technol Cancer Res Treat 2008;7:1-13.
18. Nanomedicine: application of nanobiotechnology in medical practice. Medical Principles & Practice 2008;17:89-101.
19. A Handbook of Nanomedicine. Springer/Humana, 2008.
20. Current Status and Future Prospects of Nanoneurology. J Nanoneuroscience 2008;1:56-64.
21. Role of nanobiotechnology in drug discovery. In, Guzman CA and Feuerstein G (eds) Pharmaceutical Biotechnology. Landes Press, 2009 or Adv Exp Med Biol 2009;655:37-43.
22. Nanotechnology in drug discovery. In, Seethala R (ed) ‘Handbook of Drug Screening’, 2nd edition, Informa, 2009:465-476.
23. Role of nanobiotechnology in the development of personalized medicine. Nanomed 2009;4:249-52.
24. Application of Nanobiotechnology in Cancer Therapeutics. In, Lu Y, Mahato RI (eds) Pharmaceutical Perspectives of Cancer Therapeutics. Springer, New York, 2009:245-268.
25. Potential of Nanobiotechnology in Management of Glioblastoma Multiforme. In, Ray SK (ed) Glioblastoma: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies. Springer, 2010:399-419.
26. Advances in the field of Nanooncology. BMC Medicine 2010;8:83.
27. Nanobiotechnology. Chapter 68 in, Butler E (ed) Scientific Fundamentals in Biotechnology, Volume 1, Section 6: The biophysical basis. Elsevier, Amsterdam, April 2011 (in press).
28. Role of Nanobiotechnology in the Personalized Management of Glioblastoma Multiforme. Nanomedicine 2011;6:411-4.
29. Application of nanobiotechnology in cardiovascular therapeutics. In Jain KK. Applications of Biotechnology in Cardiovascular Therapeutics, Springer, New York, August 2011.
